1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEKTAR THERAPEUTICS
Nektar Therapeutics XNAS: NKTR
73.33 1.26 (1.75%)
580.5K
XNAS Volume

XNAS 11 Mar, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Nektar Therapeutics is on 13 Mar 2026 for the purpose of Nektar Therapeutics Annual Report for 2025 See details

Nektar Therapeutics - NKTR - stock price prediction, stock price target, analyst ratings from 8 analysts

Nektar Therapeutics has a share price target of US$ 130, revenue growth forecast of -55.5%, and profit growth estimate of -48.3% for FY25, based on top 8 analyst calls.